Menke Ricarda A L, Proudfoot Malcolm, Wuu Joanne, Andersen Peter M, Talbot Kevin, Benatar Michael, Turner Martin R
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK FMRIB Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):580-8. doi: 10.1136/jnnp-2015-311945. Epub 2016 Jan 5.
To discern presymptomatic changes in brain structure or function using advanced MRI in carriers of mutations predisposing to amyotrophic lateral sclerosis (ALS).
T1-weighted, diffusion weighted and resting state functional MRI data were acquired at 3 T for 12 asymptomatic mutation carriers (psALS), 12 age-matched controls and affected patients with ALS. Cortical thickness analysis, voxel-based morphometry, volumetric and shape analyses of subcortical structures, tract-based spatial statistics of metrics derived from the diffusion tensor, and resting state functional connectivity (FC) analyses were performed.
Grey matter cortical thickness and shape analysis revealed significant atrophy in patients with ALS (but not psALS) compared with controls in the right primary motor cortex and right caudate. Comparison of diffusion tensor metrics showed widespread fractional anisotropy and radial diffusivity differences in patients with ALS compared to controls and the psALS group, encompassing parts of the corpus callosum, corticospinal tracts and superior longitudinal fasciculus. While FC in the resting-state sensorimotor network was similar in psALS and controls, FC between the cerebellum and a network comprising the precuneus, cingulate & middle frontal lobe was significantly higher in psALS and affected ALS compared to controls.
Rather than structural brain changes, increased FC may be among the earliest detectable brain abnormalities in asymptomatic carriers of ALS-causing gene mutations. With replication and significant refinement, this technique has potential in the future assessment of neuroprotective strategies.
利用先进的磁共振成像(MRI)技术,识别肌萎缩侧索硬化症(ALS)易感基因突变携带者大脑结构或功能的症状前变化。
在3T条件下,采集12名无症状突变携带者(psALS)、12名年龄匹配的对照者以及ALS患者的T1加权、扩散加权和静息态功能MRI数据。进行皮质厚度分析、基于体素的形态学分析、皮质下结构的体积和形状分析、基于扩散张量导出指标的基于纤维束的空间统计以及静息态功能连接(FC)分析。
灰质皮质厚度和形状分析显示,与对照组相比,ALS患者(而非psALS)的右侧初级运动皮质和右侧尾状核存在明显萎缩。扩散张量指标比较显示,与对照组和psALS组相比,ALS患者在胼胝体、皮质脊髓束和上纵束的部分区域存在广泛的各向异性分数和径向扩散率差异。虽然psALS和对照组静息态感觉运动网络中的FC相似,但与对照组相比,psALS和ALS患者的小脑与包括楔前叶、扣带回和额中回的网络之间的FC显著更高。
与大脑结构变化不同,FC增加可能是导致ALS基因突变的无症状携带者最早可检测到的大脑异常之一。经过重复验证和显著改进,这项技术在未来神经保护策略评估中具有潜力。